Wednesday, 07. January 2009

Home

Home
MEMBER

SHORT VIEW  DETAILED VIEW 

Gunilla Karlsson Hedestam, Associate Professor (»Add to Infobox)


Show picture in detail
Swedish Institute for Infectious Disease Control
For a more complete description of our group activities, please go to our MTC home page at: http://ki.se/research/karlsson-hedestam

Short research summary

A major focus in the group is to understand the mechanisms underlying the induction of potent B cell responses with the aim to elicit broadly neutralizing antibodies against complex viral surface antigens, such as the HIV-1 envelope glycoproteins (Env). To this end we have developed methods that allow a more comprehensive characterization of vaccine-induced Env directed antibody responses elicited in vivo as well as systems to study B cell differentiation in vitro. We employ these and other methods to investigate how B cells can be manipulated to promote the elicitation of desired antibody responses. We also use viruses such as Semliki Forest virus, rotavirus and adenovirus to investigate how anti-viral T and B cell responses are induced during virus infection. By combining in vitro cell culture systems and in vivo studies, we ask which immediate anti-viral host response pathways are induced by virus infection and what consequences these events have for the establishment of long-lived immune responses against virus-encoded antigens.

Selected Publications

A. Mörner, I. Douagi, M. N. E. Forsell, C. Sundling, P. Dosenovic, S. O dell, B. Dey, P. Kwong, G. Voss, R. Thorstensson, J. Mascola, R. Wyatt and G. B. Karlsson Hedestam "HIV-1 Env-trimer immunization of macaques and impact of priming with viral vector or stabilized core protein" (2008) J. Virol. In Press

C. Sundling, K. Schön, A. Mörner, M. N. E. Forsell, R. T. Wyatt, R. Thorstensson, G. B. Karlsson Hedestam and N. Y. Lycke "CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization" (2008) J Gen Virol ; 89: 2954 2964

M. N. Forsell, B. Dey, A. Mörner, K. Svehla, S. O'dell, C. M. Högerkorp, G. Voss, R. Thorstensson, G. M. Shaw, J. R. Mascola, G. B. Karlsson Hedestam, R. T. Wyatt "B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4." PLoS Pathog. 2008 Oct 3;4(10):e1000171.

G. B. Karlsson Hedestam, R. A. M. Fouchier, S. Phogat, D. R. Burton, J. Sodroski and R. T. Wyatt. "The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus" (2008) Nat Rev Microbiol. Feb;6(2):143-55

M. Högbom, R. Collins, S. van den Berg, R-M. Jenvert, T. Karlberg, T. Kotenyova, A. Flores, G. B. Karlsson Hedestam and L. Holmberg Schiavone "Crystal Structure of the conserved core of the human DEAD-box helicase DDX3X in complex with the mononucleotide AMP" (2007) J. Mol. Biol.372;150-159

M. N. E. Forsell, G. McInerney, P. Dosenovic, Å. S. Hidmark, C. Eriksson, P. Liljeström, C. Grundner and G. B. Karlsson Hedestam “Increased HIV-1 Env expression and antibody induction using an enhanced alphavirus vector” (2007) J. Gen Virol 88:2774-2779

L. Breakwell, Dosenovic, P., G. B. Karlsson Hedestam, M. D'Amato, P. Liljeström, J. Fazakerley, and G. M. McInerney. “Semliki Forest virus non-structural protein 2 is involved in the suppression of the type I Interferon response.” (2007) J. Virol. 81; 8677-8684

S. Phogat, R.T. Wyatt and G. B. Karlsson Hedestam "Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets" (2007) J. Internal Medicine. 262; 40-57

I. Douagi, G. McInerney, Å. S. Hidmark, V. Miriallis, K. Johansen, L. Svensson and G. B. Karlsson Hedestam “Role of IRF-3 in Type I IFN Responses in Rotavirus Infected Dendritic cells and Fibroblasts”. (2007) J. Virol. 81; 2758-2768

H. Sjölin, S. H. Robbins, Å. Hidmark, E. Tomasello, M. Johansson, G. Bessou, H. Hall, F. Charifi, C. A. Biron, K. G. B. Karlsson Hedestam, Kärre, P. Höglund, E. Vivier, M. Dalod “Differential regulation of Il-12 and IFNa/b production by endogenous DAP12 signalling in pDCs during viral infection in vivo” (2006) J. Immunol. 177; 2908-2916

Å. S. Hidmark, E. K. L. Nordström, P. Dosenovic, M. N. E. Forsell, P. Liljeström, G. B. Karlsson Hedestam "Humoral immune responses against co-administered antigen but not against alphavirus-encoded antigen require IFNa/b" (2006) J. Virol. 80; 7100-7110

M. Sundbäck, I. Douagi, C. Dajaray, M. N. E. Forsell, E. L. Nordström, G. McInerney, K. Spångberg, L. Tjäder, E. Bonin, M. Sundström, P. Liljeström and G. B. Karlsson Hedestam “Efficient expansion of HIV-1 specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles”. (2005) Virology 341: 190-202

M. N. E. Forsell, Y. Li, M. Sundbäck, K. Svehla, P. Liljeström, J. Mascola, R. Wyatt and G. B. Karlsson Hedestam “Biochemical and immunogenic characterization of soluble HIV-1 envelope glycoprotein trimers expressed by Semliki Forest virus” (2005) J. Virol. 79: 10902-10914

Å. S. Hidmark, G. M. McInerney, E. K. L. Nordström, I. Douagi, K. M. Werner, P. Liljeström, and G. B. Karlsson Hedestam “Early IFNa/b production by myeloid dendritic cells in response to UV-treated virus requires viral entry and IRF-3, but not MyD88” (2005) J. Virol. 79; 10376-10385

K. A. Reimann, A. Watson, P. J. Dailey, W. Lin, C. I. Lord, T. D. Steenbeke, M. K. Axthelm, and G. B. Karlsson. “Viral burden and disease progression in rhesus monkeys infected with chimeric simian human immunodeficiency viruses.” (1999) Virology 256; 15-21

G. B. Karlsson, M. Halloran, D. Schenten, J. Lee, P. Racz, K. Tenner-Racz, J. Manola, R. Gelman, B. Etemad-Moghadam, E. Desjardins, R. Wyatt, N. P. Gerard, L. Marcon, D. Margolin, J. Fanton, M. K. Axthelm, N. L. Letvin, and J. Sodroski. “The envelope glycoprotein ectodomains determine the efficiency of CD4+ T-lymphocyte depletion in simian-human immunodeficiency virus-infected macaques.” (1998) J. Exp. Med. 188; 1159-1171

B. Etemad-Moghadam, G. B. Karlsson, M. Halloran, Y. Sun, D. Schenten, M. Fernandes, N. Letvin, and J. Sodroski.“Characterization of Simian-Human Immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeys” (1998) J. Virol. 72; 8437-8445

G. B. Karlsson, M. Halloran, J. Li, I-W. Park, R. Gomila, K. A. Reimann, M. K. Axthelm, S. A. Iliff, N. L. Letvin, and J. Sodroski. (1997) ” Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys.” (1997) J. Virol. 71; 4218-4225

M. Farzan, H. Choe, K. Martin, L. Marcon, W. Hofmann, G. Karlsson, Y. Sun, P. Barrett, N. Marchand, N. Sullivan, N. Gerard, C. Gerard, and J. Sodroski. “Two orphan seven-transmembrane segment receptors that are expressed in CD4-positive cells support simian immunodeficinecy virus infection.” (1997) J. Exp. Med. 186; 405-411

G. B. Karlsson, F. Gao, J. Robinson, B. H. Hahn, and J. Sodroski. “Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses.” (1996) J. Virol. 70; 6136-6142


RELATED PROJECTS (3/5)   »show all

Pathways for the induction of type I interferons

Strategies to stimulate neutralizing antibodies against the HIV-1 envelope glycoproteins

Modulation of adaptive immune responses by interferon alpha/beta

RELATED DEPARTMENTS (2/2)   »show all

Swedish Institute for Infectious Disease Control

Swedish Institute for Infectious Disease Control

WORKING WITH (1/1)   »show all

Pia Dosenovic, Ph.D. Student (Department of Microbiology, Tumor and Cell Biology)

RELATED NAVIGATION FIELDS (3/3)   »show all

Principal Investigators

Host response to infection

Vaccines and therapeutics


SEARCH



»Advanced Search



OVERVIEWS

»Sitemap

»Members



INFOBOX (0/0) show all
Your infobox is empty




Powered by AVERIS